Harry Kochat, PhD, Named Director of the Plough Center for Sterile Drug Delivery Systems at UTHSC - news.uthsc.edu
Harry Kochat, PhD, has been named Director of the Plough Center for Sterile Drug Delivery Systems at UTHSC, a leadership change that may influence future sterile drug delivery research and collaborations.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on August 9, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Pharmaceutical manufacturers, especially those involved in sterile drug delivery systems and cGMP compliance. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Leadership change at the Plough Center for Sterile Drug Delivery Systems at UTHSC.
Who it affects
Pharmaceutical manufacturers, especially those involved in sterile drug delivery systems and cGMP compliance.
What you must do
Monitor the center's future research directions and potential collaboration opportunities.
Deadline
Not specified.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- FDA moves to expose hidden foreign drug factories, strengthen domestic production in sweeping rule proposal - foxbusiness.com
- The FDA let substandard factories ship these medications to the U.S. - michiganadvance.com
- Tom’s of Maine says it will remedy mold, bacteria problems found by FDA at Sanford plant - mainebiz.biz
- The FTC Challenges Companies’ Allegedly Improper Orange Book Patent Listings - skadden.com
- Alabama Board of Medical Examiners Issues Warning of Non-FDA-Approved Peptides - drugtopics.com